Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications

Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas.

Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas.

Journal: Expert opinion on biological therapy
Published: December 12, 2025

Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.

Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2025

Sequencing Cellular Therapies in the Management of Follicular Lymphoma.

Sequencing Cellular Therapies in the Management of Follicular Lymphoma.

Journal: Cells
Published: September 08, 2025

Mosunetuzumab, a CD20xCD3 bispecific T-cell engager, in granulomatosis with polyangiitis.

Mosunetuzumab, a CD20xCD3 bispecific T-cell engager, in granulomatosis with polyangiitis.

Journal: Annals of the rheumatic diseases
Published: September 03, 2025

Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers.

Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers.

Journal: Seminars in hematology
Published: August 21, 2025

Clinical representativeness of pivotal trials for T-cell engagers in relapsed/refractory follicular lymphoma.

Clinical representativeness of pivotal trials for T-cell engagers in relapsed/refractory follicular lymphoma.

Journal: Future oncology (London, England)
Published: August 13, 2025

Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives.

Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives.

Journal: Frontiers in immunology
Published: August 04, 2025

A Generalized Minimal PBPK-PD Model of Bispecific Antibodies: Case Studies and Applications in Drug Development.

A Generalized Minimal PBPK-PD Model of Bispecific Antibodies: Case Studies and Applications in Drug Development.

Journal: CPT: pharmacometrics & systems pharmacology
Published: August 04, 2025

Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma: bispecific antibodies and CAR T-Cell therapies.

Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma: bispecific antibodies and CAR T-Cell therapies.

Journal: Blood research
Published: July 22, 2025

Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies.

Richter Transformation in Chronic Lymphocytic Leukemia: Current Treatment Challenges and Evolving Therapies.

Journal: International journal of molecular sciences
Published: July 20, 2025

Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline.

Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: July 13, 2025

Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy.

Bispecific Monoclonal Antibodies in Diffuse Large B-Cell Lymphoma: Dawn of a New Era in Targeted Therapy.

Journal: Cancers
Published: July 08, 2025
Showing 1-12 of 127

Last Updated: 01/07/2026